The methodological and clinical aspects of the placebo effect in angina pectoris. 1988

A G Janicki, and K Orzechowska-Juzwenko, and T Swiderska-Błońska
Department of Clinical Pharmacology, Medical Academy, Wrocław, Poland.

The study was carried out in 45 patients (36 males and 9 females) experiencing more attacks on the evaluation of an antianginal drug in a placebo-controlled trial, and to define some conditions of placebo sensitiveness in patients with angina pectoris. The study was carried out in 45 patients (36 males and 9 females) experiencing more than 5 anginal attacks a week. The drug compared with the placebo was Iso-Mack-Retard 20 believed to have a good antianginal profile. The efficacy of both the drug and placebo was assessed mainly by the number of anginal attacks per week. The differences in the efficacy between the drug and its placebo in the group studied as a whole were not statistically significant but, after exclusion of 15 placebo-sensitive patients (placebo responders), these differences increased to become statistically significant (p less than 0.01). Moreover, the study proved that the extent of the placebo effect in a population is inversely dependent on the level of neuroticism measured by Eysenck Personality Inventory, and directly dependent on the number of anginal attacks in the period before administration of the drug.

UI MeSH Term Description Entries
D007548 Isosorbide Dinitrate A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action. Cardonit 40,Dilatrate,Iso-Bid,Isodinit,Isoket,Isoket Retard-120,Isomak R,Isordil,Isotrate,Nitrosorbide,Sorbitrate,Sorbonit,Dinitrate, Isosorbide,Iso Bid,IsoBid,Isoket Retard 120,Isoket Retard120
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010555 Personality Inventory Check list, usually to be filled out by a person about himself, consisting of many statements about personal characteristics which the subject checks. Edwards Personal Preference Schedule,Myers-Briggs Type Indicator,Indicator, Myers-Briggs Type,Inventories, Personality,Inventory, Personality,Myers Briggs Type Indicator,Personality Inventories
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A G Janicki, and K Orzechowska-Juzwenko, and T Swiderska-Błońska
November 1979, The New England journal of medicine,
A G Janicki, and K Orzechowska-Juzwenko, and T Swiderska-Błońska
June 1979, The New England journal of medicine,
A G Janicki, and K Orzechowska-Juzwenko, and T Swiderska-Błońska
September 1969, The American journal of cardiology,
A G Janicki, and K Orzechowska-Juzwenko, and T Swiderska-Błońska
February 1962, El Dia medico,
A G Janicki, and K Orzechowska-Juzwenko, and T Swiderska-Błońska
January 1978, Acta cardiologica,
A G Janicki, and K Orzechowska-Juzwenko, and T Swiderska-Błońska
January 1980, Circulation,
A G Janicki, and K Orzechowska-Juzwenko, and T Swiderska-Błońska
June 1996, Medizinische Klinik (Munich, Germany : 1983),
A G Janicki, and K Orzechowska-Juzwenko, and T Swiderska-Błońska
June 1959, Bulletin of the Johns Hopkins Hospital,
A G Janicki, and K Orzechowska-Juzwenko, and T Swiderska-Błońska
July 1974, The New England journal of medicine,
A G Janicki, and K Orzechowska-Juzwenko, and T Swiderska-Błońska
January 1957, Terapevticheskii arkhiv,
Copied contents to your clipboard!